Get the latest tech news
Controversial genetics testing startup Nucleus Genomics raises $14M Series A
The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that gets saliva samples sequenced and then compares the DNA results to extensive data linking health issues to genes. Today, Nucleus, staffed by a team of PhDs and genetic experts, charges $400 to send a saliva sample to a third party sequencer and then analyze the results, telling users a host of potential illnesses they may be at risk for. Sadeghi’s approach is also markedly different from competitors: Back in 2018, 23andMe told the MIT Technology Review it purposefully wouldn’t release consumer information around genetics and intelligence for fear of “misinterpretation.”
Or read this on TechCrunch
